nodes	percent_of_prediction	percent_of_DWPC	metapath
Telmisartan—ABCB1—ovarian cancer	0.234	1	CbGaD
Telmisartan—SLCO1B3—Paclitaxel—ovarian cancer	0.0821	0.149	CbGbCtD
Telmisartan—ABCG2—Topotecan—ovarian cancer	0.0768	0.139	CbGbCtD
Telmisartan—SLCO1B3—Docetaxel—ovarian cancer	0.0594	0.107	CbGbCtD
Telmisartan—ABCC2—Paclitaxel—ovarian cancer	0.042	0.076	CbGbCtD
Telmisartan—ABCC2—Carboplatin—ovarian cancer	0.0396	0.0715	CbGbCtD
Telmisartan—ABCG2—Paclitaxel—ovarian cancer	0.038	0.0687	CbGbCtD
Telmisartan—ABCG2—Carboplatin—ovarian cancer	0.0358	0.0647	CbGbCtD
Telmisartan—ABCC2—Docetaxel—ovarian cancer	0.0304	0.055	CbGbCtD
Telmisartan—ABCB1—Topotecan—ovarian cancer	0.0277	0.0501	CbGbCtD
Telmisartan—ABCG2—Docetaxel—ovarian cancer	0.0275	0.0497	CbGbCtD
Telmisartan—ABCC2—Doxorubicin—ovarian cancer	0.0227	0.041	CbGbCtD
Telmisartan—ABCG2—Doxorubicin—ovarian cancer	0.0205	0.037	CbGbCtD
Telmisartan—ABCB1—Vinorelbine—ovarian cancer	0.0195	0.0353	CbGbCtD
Telmisartan—ABCB1—Paclitaxel—ovarian cancer	0.0137	0.0248	CbGbCtD
Telmisartan—ABCB1—Docetaxel—ovarian cancer	0.00991	0.0179	CbGbCtD
Telmisartan—ABCB1—Doxorubicin—ovarian cancer	0.00738	0.0134	CbGbCtD
Telmisartan—PPARG—Irinotecan—Topotecan—ovarian cancer	0.00342	1	CbGdCrCtD
Telmisartan—AGTR1—myometrium—ovarian cancer	0.00161	0.0549	CbGeAlD
Telmisartan—SLCO1B3—vagina—ovarian cancer	0.0014	0.0478	CbGeAlD
Telmisartan—PPARG—embryo—ovarian cancer	0.00127	0.0434	CbGeAlD
Telmisartan—AGTR1—epithelium—ovarian cancer	0.00126	0.0431	CbGeAlD
Telmisartan—AGTR1—uterine cervix—ovarian cancer	0.00125	0.0427	CbGeAlD
Telmisartan—AGTR1—decidua—ovarian cancer	0.00119	0.0407	CbGeAlD
Telmisartan—PPARG—epithelium—ovarian cancer	0.00104	0.0355	CbGeAlD
Telmisartan—PPARG—decidua—ovarian cancer	0.000982	0.0335	CbGeAlD
Telmisartan—AGTR1—female reproductive system—ovarian cancer	0.000939	0.032	CbGeAlD
Telmisartan—PPARG—uterus—ovarian cancer	0.000859	0.0293	CbGeAlD
Telmisartan—AGTR1—vagina—ovarian cancer	0.00085	0.029	CbGeAlD
Telmisartan—ABCG2—myometrium—ovarian cancer	0.000849	0.029	CbGeAlD
Telmisartan—PPARG—female reproductive system—ovarian cancer	0.000773	0.0263	CbGeAlD
Telmisartan—AGTR1—testis—ovarian cancer	0.000758	0.0258	CbGeAlD
Telmisartan—PPARG—bone marrow—ovarian cancer	0.000729	0.0249	CbGeAlD
Telmisartan—PPARG—female gonad—ovarian cancer	0.000703	0.024	CbGeAlD
Telmisartan—PPARG—vagina—ovarian cancer	0.000699	0.0238	CbGeAlD
Telmisartan—ABCC2—female reproductive system—ovarian cancer	0.000679	0.0232	CbGeAlD
Telmisartan—ABCG2—uterine cervix—ovarian cancer	0.000661	0.0225	CbGeAlD
Telmisartan—ABCG2—decidua—ovarian cancer	0.00063	0.0215	CbGeAlD
Telmisartan—PPARG—testis—ovarian cancer	0.000623	0.0213	CbGeAlD
Telmisartan—ABCG2—endometrium—ovarian cancer	0.000598	0.0204	CbGeAlD
Telmisartan—ABCG2—uterus—ovarian cancer	0.000551	0.0188	CbGeAlD
Telmisartan—AGTR1—lymph node—ovarian cancer	0.00055	0.0187	CbGeAlD
Telmisartan—ABCC2—testis—ovarian cancer	0.000548	0.0187	CbGeAlD
Telmisartan—CYP2C19—vagina—ovarian cancer	0.000528	0.018	CbGeAlD
Telmisartan—ABCG2—bone marrow—ovarian cancer	0.000468	0.0159	CbGeAlD
Telmisartan—PPARG—lymph node—ovarian cancer	0.000452	0.0154	CbGeAlD
Telmisartan—ABCG2—female gonad—ovarian cancer	0.000451	0.0154	CbGeAlD
Telmisartan—ABCG2—vagina—ovarian cancer	0.000448	0.0153	CbGeAlD
Telmisartan—ABCB1—myometrium—ovarian cancer	0.000419	0.0143	CbGeAlD
Telmisartan—ABCB1—embryo—ovarian cancer	0.000403	0.0137	CbGeAlD
Telmisartan—ABCG2—testis—ovarian cancer	0.0004	0.0136	CbGeAlD
Telmisartan—ABCC2—lymph node—ovarian cancer	0.000397	0.0135	CbGeAlD
Telmisartan—ABCB1—epithelium—ovarian cancer	0.000329	0.0112	CbGeAlD
Telmisartan—ABCB1—uterine cervix—ovarian cancer	0.000326	0.0111	CbGeAlD
Telmisartan—ABCB1—decidua—ovarian cancer	0.000311	0.0106	CbGeAlD
Telmisartan—ABCB1—endometrium—ovarian cancer	0.000295	0.01	CbGeAlD
Telmisartan—ABCG2—lymph node—ovarian cancer	0.00029	0.00988	CbGeAlD
Telmisartan—ABCB1—gonad—ovarian cancer	0.000273	0.00932	CbGeAlD
Telmisartan—ABCB1—uterus—ovarian cancer	0.000272	0.00926	CbGeAlD
Telmisartan—ABCB1—female reproductive system—ovarian cancer	0.000244	0.00832	CbGeAlD
Telmisartan—ABCB1—bone marrow—ovarian cancer	0.000231	0.00786	CbGeAlD
Telmisartan—ABCB1—female gonad—ovarian cancer	0.000222	0.00758	CbGeAlD
Telmisartan—ABCB1—vagina—ovarian cancer	0.000221	0.00753	CbGeAlD
Telmisartan—ABCB1—testis—ovarian cancer	0.000197	0.00672	CbGeAlD
Telmisartan—ABCB1—lymph node—ovarian cancer	0.000143	0.00487	CbGeAlD
Telmisartan—Hypertension—Docetaxel—ovarian cancer	0.000112	0.000746	CcSEcCtD
Telmisartan—Infestation—Epirubicin—ovarian cancer	0.000112	0.000746	CcSEcCtD
Telmisartan—Infestation NOS—Epirubicin—ovarian cancer	0.000112	0.000746	CcSEcCtD
Telmisartan—Bronchitis—Doxorubicin—ovarian cancer	0.000112	0.000745	CcSEcCtD
Telmisartan—Dyspnoea—Paclitaxel—ovarian cancer	0.000111	0.000742	CcSEcCtD
Telmisartan—Somnolence—Paclitaxel—ovarian cancer	0.000111	0.00074	CcSEcCtD
Telmisartan—Chest pain—Docetaxel—ovarian cancer	0.00011	0.000736	CcSEcCtD
Telmisartan—Arthralgia—Docetaxel—ovarian cancer	0.00011	0.000736	CcSEcCtD
Telmisartan—Myalgia—Docetaxel—ovarian cancer	0.00011	0.000736	CcSEcCtD
Telmisartan—Nausea—Vinorelbine—ovarian cancer	0.00011	0.000735	CcSEcCtD
Telmisartan—Renal failure—Epirubicin—ovarian cancer	0.00011	0.000734	CcSEcCtD
Telmisartan—Dyspepsia—Paclitaxel—ovarian cancer	0.00011	0.000733	CcSEcCtD
Telmisartan—Neuropathy peripheral—Epirubicin—ovarian cancer	0.00011	0.000732	CcSEcCtD
Telmisartan—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—ovarian cancer	0.00011	0.000731	CcSEcCtD
Telmisartan—Conjunctivitis—Epirubicin—ovarian cancer	0.000109	0.000725	CcSEcCtD
Telmisartan—Urinary tract infection—Epirubicin—ovarian cancer	0.000109	0.000725	CcSEcCtD
Telmisartan—Dysuria—Doxorubicin—ovarian cancer	0.000109	0.000724	CcSEcCtD
Telmisartan—Decreased appetite—Paclitaxel—ovarian cancer	0.000109	0.000724	CcSEcCtD
Telmisartan—Dry mouth—Docetaxel—ovarian cancer	0.000108	0.00072	CcSEcCtD
Telmisartan—Upper respiratory tract infection—Doxorubicin—ovarian cancer	0.000108	0.00072	CcSEcCtD
Telmisartan—Gastrointestinal disorder—Paclitaxel—ovarian cancer	0.000108	0.000719	CcSEcCtD
Telmisartan—Fatigue—Paclitaxel—ovarian cancer	0.000108	0.000718	CcSEcCtD
Telmisartan—Pollakiuria—Doxorubicin—ovarian cancer	0.000107	0.000715	CcSEcCtD
Telmisartan—Pain—Paclitaxel—ovarian cancer	0.000107	0.000712	CcSEcCtD
Telmisartan—Constipation—Paclitaxel—ovarian cancer	0.000107	0.000712	CcSEcCtD
Telmisartan—Haematuria—Epirubicin—ovarian cancer	0.000107	0.000712	CcSEcCtD
Telmisartan—Hepatobiliary disease—Epirubicin—ovarian cancer	0.000106	0.000706	CcSEcCtD
Telmisartan—Oedema—Docetaxel—ovarian cancer	0.000106	0.000706	CcSEcCtD
Telmisartan—Anaphylactic shock—Docetaxel—ovarian cancer	0.000106	0.000706	CcSEcCtD
Telmisartan—Epistaxis—Epirubicin—ovarian cancer	0.000106	0.000704	CcSEcCtD
Telmisartan—Infection—Docetaxel—ovarian cancer	0.000105	0.000701	CcSEcCtD
Telmisartan—Sinusitis—Epirubicin—ovarian cancer	0.000105	0.0007	CcSEcCtD
Telmisartan—Pneumonia—Doxorubicin—ovarian cancer	0.000104	0.000695	CcSEcCtD
Telmisartan—Shock—Docetaxel—ovarian cancer	0.000104	0.000694	CcSEcCtD
Telmisartan—Nervous system disorder—Docetaxel—ovarian cancer	0.000104	0.000692	CcSEcCtD
Telmisartan—Thrombocytopenia—Docetaxel—ovarian cancer	0.000104	0.000691	CcSEcCtD
Telmisartan—Infestation—Doxorubicin—ovarian cancer	0.000104	0.00069	CcSEcCtD
Telmisartan—Infestation NOS—Doxorubicin—ovarian cancer	0.000104	0.00069	CcSEcCtD
Telmisartan—Tachycardia—Docetaxel—ovarian cancer	0.000103	0.000689	CcSEcCtD
Telmisartan—Feeling abnormal—Paclitaxel—ovarian cancer	0.000103	0.000686	CcSEcCtD
Telmisartan—Skin disorder—Docetaxel—ovarian cancer	0.000103	0.000685	CcSEcCtD
Telmisartan—Bradycardia—Epirubicin—ovarian cancer	0.000102	0.000682	CcSEcCtD
Telmisartan—Gastrointestinal pain—Paclitaxel—ovarian cancer	0.000102	0.000681	CcSEcCtD
Telmisartan—Renal failure—Doxorubicin—ovarian cancer	0.000102	0.000679	CcSEcCtD
Telmisartan—Neuropathy peripheral—Doxorubicin—ovarian cancer	0.000102	0.000677	CcSEcCtD
Telmisartan—Anorexia—Docetaxel—ovarian cancer	0.000101	0.000673	CcSEcCtD
Telmisartan—Rhinitis—Epirubicin—ovarian cancer	0.000101	0.000672	CcSEcCtD
Telmisartan—Urinary tract infection—Doxorubicin—ovarian cancer	0.000101	0.000671	CcSEcCtD
Telmisartan—Conjunctivitis—Doxorubicin—ovarian cancer	0.000101	0.000671	CcSEcCtD
Telmisartan—Hypoaesthesia—Epirubicin—ovarian cancer	0.0001	0.000667	CcSEcCtD
Telmisartan—Pharyngitis—Epirubicin—ovarian cancer	9.98e-05	0.000665	CcSEcCtD
Telmisartan—Urinary tract disorder—Epirubicin—ovarian cancer	9.93e-05	0.000662	CcSEcCtD
Telmisartan—Urticaria—Paclitaxel—ovarian cancer	9.93e-05	0.000661	CcSEcCtD
Telmisartan—Oedema peripheral—Epirubicin—ovarian cancer	9.9e-05	0.00066	CcSEcCtD
Telmisartan—Hypotension—Docetaxel—ovarian cancer	9.9e-05	0.000659	CcSEcCtD
Telmisartan—Haematuria—Doxorubicin—ovarian cancer	9.88e-05	0.000658	CcSEcCtD
Telmisartan—Connective tissue disorder—Epirubicin—ovarian cancer	9.88e-05	0.000658	CcSEcCtD
Telmisartan—Body temperature increased—Paclitaxel—ovarian cancer	9.88e-05	0.000658	CcSEcCtD
Telmisartan—Abdominal pain—Paclitaxel—ovarian cancer	9.88e-05	0.000658	CcSEcCtD
Telmisartan—Urethral disorder—Epirubicin—ovarian cancer	9.86e-05	0.000657	CcSEcCtD
Telmisartan—Hepatobiliary disease—Doxorubicin—ovarian cancer	9.8e-05	0.000653	CcSEcCtD
Telmisartan—Epistaxis—Doxorubicin—ovarian cancer	9.77e-05	0.000651	CcSEcCtD
Telmisartan—Sinusitis—Doxorubicin—ovarian cancer	9.72e-05	0.000648	CcSEcCtD
Telmisartan—Visual impairment—Epirubicin—ovarian cancer	9.69e-05	0.000646	CcSEcCtD
Telmisartan—Musculoskeletal discomfort—Docetaxel—ovarian cancer	9.65e-05	0.000643	CcSEcCtD
Telmisartan—Insomnia—Docetaxel—ovarian cancer	9.58e-05	0.000638	CcSEcCtD
Telmisartan—Paraesthesia—Docetaxel—ovarian cancer	9.51e-05	0.000634	CcSEcCtD
Telmisartan—Bradycardia—Doxorubicin—ovarian cancer	9.47e-05	0.000631	CcSEcCtD
Telmisartan—Dyspnoea—Docetaxel—ovarian cancer	9.44e-05	0.000629	CcSEcCtD
Telmisartan—Somnolence—Docetaxel—ovarian cancer	9.41e-05	0.000627	CcSEcCtD
Telmisartan—Eye disorder—Epirubicin—ovarian cancer	9.4e-05	0.000626	CcSEcCtD
Telmisartan—Tinnitus—Epirubicin—ovarian cancer	9.37e-05	0.000625	CcSEcCtD
Telmisartan—Flushing—Epirubicin—ovarian cancer	9.33e-05	0.000622	CcSEcCtD
Telmisartan—Cardiac disorder—Epirubicin—ovarian cancer	9.33e-05	0.000622	CcSEcCtD
Telmisartan—Rhinitis—Doxorubicin—ovarian cancer	9.33e-05	0.000621	CcSEcCtD
Telmisartan—Dyspepsia—Docetaxel—ovarian cancer	9.32e-05	0.000621	CcSEcCtD
Telmisartan—Hypoaesthesia—Doxorubicin—ovarian cancer	9.26e-05	0.000617	CcSEcCtD
Telmisartan—Pharyngitis—Doxorubicin—ovarian cancer	9.23e-05	0.000615	CcSEcCtD
Telmisartan—Decreased appetite—Docetaxel—ovarian cancer	9.21e-05	0.000613	CcSEcCtD
Telmisartan—Hypersensitivity—Paclitaxel—ovarian cancer	9.2e-05	0.000613	CcSEcCtD
Telmisartan—Urinary tract disorder—Doxorubicin—ovarian cancer	9.19e-05	0.000612	CcSEcCtD
Telmisartan—Oedema peripheral—Doxorubicin—ovarian cancer	9.16e-05	0.000611	CcSEcCtD
Telmisartan—Gastrointestinal disorder—Docetaxel—ovarian cancer	9.14e-05	0.000609	CcSEcCtD
Telmisartan—Connective tissue disorder—Doxorubicin—ovarian cancer	9.14e-05	0.000609	CcSEcCtD
Telmisartan—Fatigue—Docetaxel—ovarian cancer	9.13e-05	0.000608	CcSEcCtD
Telmisartan—Angiopathy—Epirubicin—ovarian cancer	9.12e-05	0.000608	CcSEcCtD
Telmisartan—Urethral disorder—Doxorubicin—ovarian cancer	9.12e-05	0.000608	CcSEcCtD
Telmisartan—Immune system disorder—Epirubicin—ovarian cancer	9.08e-05	0.000605	CcSEcCtD
Telmisartan—Mediastinal disorder—Epirubicin—ovarian cancer	9.06e-05	0.000604	CcSEcCtD
Telmisartan—Constipation—Docetaxel—ovarian cancer	9.06e-05	0.000603	CcSEcCtD
Telmisartan—Pain—Docetaxel—ovarian cancer	9.06e-05	0.000603	CcSEcCtD
Telmisartan—Chills—Epirubicin—ovarian cancer	9.02e-05	0.000601	CcSEcCtD
Telmisartan—Arrhythmia—Epirubicin—ovarian cancer	8.98e-05	0.000598	CcSEcCtD
Telmisartan—Visual impairment—Doxorubicin—ovarian cancer	8.96e-05	0.000597	CcSEcCtD
Telmisartan—Asthenia—Paclitaxel—ovarian cancer	8.96e-05	0.000597	CcSEcCtD
Telmisartan—Pruritus—Paclitaxel—ovarian cancer	8.84e-05	0.000589	CcSEcCtD
Telmisartan—Mental disorder—Epirubicin—ovarian cancer	8.81e-05	0.000587	CcSEcCtD
Telmisartan—Erythema—Epirubicin—ovarian cancer	8.75e-05	0.000583	CcSEcCtD
Telmisartan—Malnutrition—Epirubicin—ovarian cancer	8.75e-05	0.000583	CcSEcCtD
Telmisartan—Feeling abnormal—Docetaxel—ovarian cancer	8.73e-05	0.000581	CcSEcCtD
Telmisartan—Eye disorder—Doxorubicin—ovarian cancer	8.69e-05	0.000579	CcSEcCtD
Telmisartan—Tinnitus—Doxorubicin—ovarian cancer	8.67e-05	0.000578	CcSEcCtD
Telmisartan—Gastrointestinal pain—Docetaxel—ovarian cancer	8.66e-05	0.000577	CcSEcCtD
Telmisartan—Flushing—Doxorubicin—ovarian cancer	8.63e-05	0.000575	CcSEcCtD
Telmisartan—Cardiac disorder—Doxorubicin—ovarian cancer	8.63e-05	0.000575	CcSEcCtD
Telmisartan—Flatulence—Epirubicin—ovarian cancer	8.62e-05	0.000575	CcSEcCtD
Telmisartan—Tension—Epirubicin—ovarian cancer	8.59e-05	0.000572	CcSEcCtD
Telmisartan—Dysgeusia—Epirubicin—ovarian cancer	8.57e-05	0.000571	CcSEcCtD
Telmisartan—Diarrhoea—Paclitaxel—ovarian cancer	8.55e-05	0.00057	CcSEcCtD
Telmisartan—Nervousness—Epirubicin—ovarian cancer	8.5e-05	0.000566	CcSEcCtD
Telmisartan—Back pain—Epirubicin—ovarian cancer	8.47e-05	0.000564	CcSEcCtD
Telmisartan—Angiopathy—Doxorubicin—ovarian cancer	8.44e-05	0.000562	CcSEcCtD
Telmisartan—Muscle spasms—Epirubicin—ovarian cancer	8.41e-05	0.000561	CcSEcCtD
Telmisartan—Immune system disorder—Doxorubicin—ovarian cancer	8.4e-05	0.00056	CcSEcCtD
Telmisartan—Mediastinal disorder—Doxorubicin—ovarian cancer	8.38e-05	0.000559	CcSEcCtD
Telmisartan—Body temperature increased—Docetaxel—ovarian cancer	8.37e-05	0.000558	CcSEcCtD
Telmisartan—Abdominal pain—Docetaxel—ovarian cancer	8.37e-05	0.000558	CcSEcCtD
Telmisartan—Chills—Doxorubicin—ovarian cancer	8.35e-05	0.000556	CcSEcCtD
Telmisartan—Arrhythmia—Doxorubicin—ovarian cancer	8.31e-05	0.000554	CcSEcCtD
Telmisartan—Dizziness—Paclitaxel—ovarian cancer	8.26e-05	0.000551	CcSEcCtD
Telmisartan—Mental disorder—Doxorubicin—ovarian cancer	8.15e-05	0.000543	CcSEcCtD
Telmisartan—Ill-defined disorder—Epirubicin—ovarian cancer	8.12e-05	0.000541	CcSEcCtD
Telmisartan—Erythema—Doxorubicin—ovarian cancer	8.1e-05	0.00054	CcSEcCtD
Telmisartan—Malnutrition—Doxorubicin—ovarian cancer	8.1e-05	0.00054	CcSEcCtD
Telmisartan—Anaemia—Epirubicin—ovarian cancer	8.09e-05	0.000539	CcSEcCtD
Telmisartan—Flatulence—Doxorubicin—ovarian cancer	7.98e-05	0.000532	CcSEcCtD
Telmisartan—Tension—Doxorubicin—ovarian cancer	7.95e-05	0.00053	CcSEcCtD
Telmisartan—Vomiting—Paclitaxel—ovarian cancer	7.94e-05	0.000529	CcSEcCtD
Telmisartan—Dysgeusia—Doxorubicin—ovarian cancer	7.93e-05	0.000528	CcSEcCtD
Telmisartan—Malaise—Epirubicin—ovarian cancer	7.89e-05	0.000526	CcSEcCtD
Telmisartan—Rash—Paclitaxel—ovarian cancer	7.88e-05	0.000525	CcSEcCtD
Telmisartan—Dermatitis—Paclitaxel—ovarian cancer	7.87e-05	0.000524	CcSEcCtD
Telmisartan—Nervousness—Doxorubicin—ovarian cancer	7.87e-05	0.000524	CcSEcCtD
Telmisartan—Vertigo—Epirubicin—ovarian cancer	7.86e-05	0.000524	CcSEcCtD
Telmisartan—Syncope—Epirubicin—ovarian cancer	7.85e-05	0.000523	CcSEcCtD
Telmisartan—Back pain—Doxorubicin—ovarian cancer	7.83e-05	0.000522	CcSEcCtD
Telmisartan—Headache—Paclitaxel—ovarian cancer	7.83e-05	0.000522	CcSEcCtD
Telmisartan—Hypersensitivity—Docetaxel—ovarian cancer	7.8e-05	0.00052	CcSEcCtD
Telmisartan—Muscle spasms—Doxorubicin—ovarian cancer	7.79e-05	0.000519	CcSEcCtD
Telmisartan—Palpitations—Epirubicin—ovarian cancer	7.73e-05	0.000515	CcSEcCtD
Telmisartan—Loss of consciousness—Epirubicin—ovarian cancer	7.69e-05	0.000513	CcSEcCtD
Telmisartan—Cough—Epirubicin—ovarian cancer	7.64e-05	0.000509	CcSEcCtD
Telmisartan—Asthenia—Docetaxel—ovarian cancer	7.6e-05	0.000506	CcSEcCtD
Telmisartan—Hypertension—Epirubicin—ovarian cancer	7.56e-05	0.000503	CcSEcCtD
Telmisartan—Ill-defined disorder—Doxorubicin—ovarian cancer	7.51e-05	0.000501	CcSEcCtD
Telmisartan—Pruritus—Docetaxel—ovarian cancer	7.49e-05	0.000499	CcSEcCtD
Telmisartan—Anaemia—Doxorubicin—ovarian cancer	7.48e-05	0.000499	CcSEcCtD
Telmisartan—Chest pain—Epirubicin—ovarian cancer	7.45e-05	0.000496	CcSEcCtD
Telmisartan—Arthralgia—Epirubicin—ovarian cancer	7.45e-05	0.000496	CcSEcCtD
Telmisartan—Myalgia—Epirubicin—ovarian cancer	7.45e-05	0.000496	CcSEcCtD
Telmisartan—Anxiety—Epirubicin—ovarian cancer	7.43e-05	0.000495	CcSEcCtD
Telmisartan—Nausea—Paclitaxel—ovarian cancer	7.42e-05	0.000494	CcSEcCtD
Telmisartan—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—ovarian cancer	7.4e-05	0.000493	CcSEcCtD
Telmisartan—Discomfort—Epirubicin—ovarian cancer	7.36e-05	0.000491	CcSEcCtD
Telmisartan—Malaise—Doxorubicin—ovarian cancer	7.3e-05	0.000487	CcSEcCtD
Telmisartan—Dry mouth—Epirubicin—ovarian cancer	7.29e-05	0.000486	CcSEcCtD
Telmisartan—Vertigo—Doxorubicin—ovarian cancer	7.28e-05	0.000485	CcSEcCtD
Telmisartan—Syncope—Doxorubicin—ovarian cancer	7.26e-05	0.000484	CcSEcCtD
Telmisartan—Diarrhoea—Docetaxel—ovarian cancer	7.25e-05	0.000483	CcSEcCtD
Telmisartan—Palpitations—Doxorubicin—ovarian cancer	7.16e-05	0.000477	CcSEcCtD
Telmisartan—Oedema—Epirubicin—ovarian cancer	7.14e-05	0.000476	CcSEcCtD
Telmisartan—Anaphylactic shock—Epirubicin—ovarian cancer	7.14e-05	0.000476	CcSEcCtD
Telmisartan—Loss of consciousness—Doxorubicin—ovarian cancer	7.12e-05	0.000474	CcSEcCtD
Telmisartan—Infection—Epirubicin—ovarian cancer	7.1e-05	0.000473	CcSEcCtD
Telmisartan—Cough—Doxorubicin—ovarian cancer	7.07e-05	0.000471	CcSEcCtD
Telmisartan—Shock—Epirubicin—ovarian cancer	7.03e-05	0.000468	CcSEcCtD
Telmisartan—Nervous system disorder—Epirubicin—ovarian cancer	7e-05	0.000467	CcSEcCtD
Telmisartan—Dizziness—Docetaxel—ovarian cancer	7e-05	0.000467	CcSEcCtD
Telmisartan—Thrombocytopenia—Epirubicin—ovarian cancer	6.99e-05	0.000466	CcSEcCtD
Telmisartan—Hypertension—Doxorubicin—ovarian cancer	6.99e-05	0.000466	CcSEcCtD
Telmisartan—Tachycardia—Epirubicin—ovarian cancer	6.97e-05	0.000465	CcSEcCtD
Telmisartan—Skin disorder—Epirubicin—ovarian cancer	6.94e-05	0.000462	CcSEcCtD
Telmisartan—Hyperhidrosis—Epirubicin—ovarian cancer	6.91e-05	0.00046	CcSEcCtD
Telmisartan—Arthralgia—Doxorubicin—ovarian cancer	6.89e-05	0.000459	CcSEcCtD
Telmisartan—Chest pain—Doxorubicin—ovarian cancer	6.89e-05	0.000459	CcSEcCtD
Telmisartan—Myalgia—Doxorubicin—ovarian cancer	6.89e-05	0.000459	CcSEcCtD
Telmisartan—Anxiety—Doxorubicin—ovarian cancer	6.87e-05	0.000458	CcSEcCtD
Telmisartan—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—ovarian cancer	6.85e-05	0.000456	CcSEcCtD
Telmisartan—Discomfort—Doxorubicin—ovarian cancer	6.81e-05	0.000454	CcSEcCtD
Telmisartan—Anorexia—Epirubicin—ovarian cancer	6.81e-05	0.000454	CcSEcCtD
Telmisartan—Dry mouth—Doxorubicin—ovarian cancer	6.74e-05	0.000449	CcSEcCtD
Telmisartan—Vomiting—Docetaxel—ovarian cancer	6.73e-05	0.000449	CcSEcCtD
Telmisartan—Rash—Docetaxel—ovarian cancer	6.68e-05	0.000445	CcSEcCtD
Telmisartan—Hypotension—Epirubicin—ovarian cancer	6.67e-05	0.000445	CcSEcCtD
Telmisartan—Dermatitis—Docetaxel—ovarian cancer	6.67e-05	0.000445	CcSEcCtD
Telmisartan—Headache—Docetaxel—ovarian cancer	6.63e-05	0.000442	CcSEcCtD
Telmisartan—Oedema—Doxorubicin—ovarian cancer	6.61e-05	0.00044	CcSEcCtD
Telmisartan—Anaphylactic shock—Doxorubicin—ovarian cancer	6.61e-05	0.00044	CcSEcCtD
Telmisartan—Infection—Doxorubicin—ovarian cancer	6.57e-05	0.000438	CcSEcCtD
Telmisartan—Musculoskeletal discomfort—Epirubicin—ovarian cancer	6.51e-05	0.000434	CcSEcCtD
Telmisartan—Shock—Doxorubicin—ovarian cancer	6.5e-05	0.000433	CcSEcCtD
Telmisartan—Nervous system disorder—Doxorubicin—ovarian cancer	6.48e-05	0.000432	CcSEcCtD
Telmisartan—Thrombocytopenia—Doxorubicin—ovarian cancer	6.47e-05	0.000431	CcSEcCtD
Telmisartan—Insomnia—Epirubicin—ovarian cancer	6.46e-05	0.00043	CcSEcCtD
Telmisartan—Tachycardia—Doxorubicin—ovarian cancer	6.45e-05	0.00043	CcSEcCtD
Telmisartan—Skin disorder—Doxorubicin—ovarian cancer	6.42e-05	0.000428	CcSEcCtD
Telmisartan—Paraesthesia—Epirubicin—ovarian cancer	6.41e-05	0.000427	CcSEcCtD
Telmisartan—Hyperhidrosis—Doxorubicin—ovarian cancer	6.39e-05	0.000426	CcSEcCtD
Telmisartan—Dyspnoea—Epirubicin—ovarian cancer	6.37e-05	0.000424	CcSEcCtD
Telmisartan—Somnolence—Epirubicin—ovarian cancer	6.35e-05	0.000423	CcSEcCtD
Telmisartan—Anorexia—Doxorubicin—ovarian cancer	6.3e-05	0.00042	CcSEcCtD
Telmisartan—Nausea—Docetaxel—ovarian cancer	6.29e-05	0.000419	CcSEcCtD
Telmisartan—Dyspepsia—Epirubicin—ovarian cancer	6.29e-05	0.000419	CcSEcCtD
Telmisartan—Decreased appetite—Epirubicin—ovarian cancer	6.21e-05	0.000414	CcSEcCtD
Telmisartan—Hypotension—Doxorubicin—ovarian cancer	6.18e-05	0.000412	CcSEcCtD
Telmisartan—Gastrointestinal disorder—Epirubicin—ovarian cancer	6.17e-05	0.000411	CcSEcCtD
Telmisartan—Fatigue—Epirubicin—ovarian cancer	6.16e-05	0.00041	CcSEcCtD
Telmisartan—Constipation—Epirubicin—ovarian cancer	6.11e-05	0.000407	CcSEcCtD
Telmisartan—Pain—Epirubicin—ovarian cancer	6.11e-05	0.000407	CcSEcCtD
Telmisartan—Musculoskeletal discomfort—Doxorubicin—ovarian cancer	6.02e-05	0.000401	CcSEcCtD
Telmisartan—Insomnia—Doxorubicin—ovarian cancer	5.98e-05	0.000398	CcSEcCtD
Telmisartan—Paraesthesia—Doxorubicin—ovarian cancer	5.93e-05	0.000395	CcSEcCtD
Telmisartan—Dyspnoea—Doxorubicin—ovarian cancer	5.89e-05	0.000393	CcSEcCtD
Telmisartan—Feeling abnormal—Epirubicin—ovarian cancer	5.89e-05	0.000392	CcSEcCtD
Telmisartan—Somnolence—Doxorubicin—ovarian cancer	5.88e-05	0.000392	CcSEcCtD
Telmisartan—Gastrointestinal pain—Epirubicin—ovarian cancer	5.84e-05	0.000389	CcSEcCtD
Telmisartan—Dyspepsia—Doxorubicin—ovarian cancer	5.82e-05	0.000388	CcSEcCtD
Telmisartan—Decreased appetite—Doxorubicin—ovarian cancer	5.75e-05	0.000383	CcSEcCtD
Telmisartan—Gastrointestinal disorder—Doxorubicin—ovarian cancer	5.71e-05	0.00038	CcSEcCtD
Telmisartan—Fatigue—Doxorubicin—ovarian cancer	5.7e-05	0.00038	CcSEcCtD
Telmisartan—Urticaria—Epirubicin—ovarian cancer	5.67e-05	0.000378	CcSEcCtD
Telmisartan—Constipation—Doxorubicin—ovarian cancer	5.65e-05	0.000377	CcSEcCtD
Telmisartan—Pain—Doxorubicin—ovarian cancer	5.65e-05	0.000377	CcSEcCtD
Telmisartan—Abdominal pain—Epirubicin—ovarian cancer	5.65e-05	0.000376	CcSEcCtD
Telmisartan—Body temperature increased—Epirubicin—ovarian cancer	5.65e-05	0.000376	CcSEcCtD
Telmisartan—Feeling abnormal—Doxorubicin—ovarian cancer	5.45e-05	0.000363	CcSEcCtD
Telmisartan—Gastrointestinal pain—Doxorubicin—ovarian cancer	5.4e-05	0.00036	CcSEcCtD
Telmisartan—Hypersensitivity—Epirubicin—ovarian cancer	5.26e-05	0.000351	CcSEcCtD
Telmisartan—Urticaria—Doxorubicin—ovarian cancer	5.25e-05	0.00035	CcSEcCtD
Telmisartan—Abdominal pain—Doxorubicin—ovarian cancer	5.22e-05	0.000348	CcSEcCtD
Telmisartan—Body temperature increased—Doxorubicin—ovarian cancer	5.22e-05	0.000348	CcSEcCtD
Telmisartan—Asthenia—Epirubicin—ovarian cancer	5.12e-05	0.000341	CcSEcCtD
Telmisartan—Pruritus—Epirubicin—ovarian cancer	5.05e-05	0.000337	CcSEcCtD
Telmisartan—Diarrhoea—Epirubicin—ovarian cancer	4.89e-05	0.000326	CcSEcCtD
Telmisartan—Hypersensitivity—Doxorubicin—ovarian cancer	4.87e-05	0.000324	CcSEcCtD
Telmisartan—Asthenia—Doxorubicin—ovarian cancer	4.74e-05	0.000316	CcSEcCtD
Telmisartan—Dizziness—Epirubicin—ovarian cancer	4.72e-05	0.000315	CcSEcCtD
Telmisartan—Pruritus—Doxorubicin—ovarian cancer	4.68e-05	0.000312	CcSEcCtD
Telmisartan—Vomiting—Epirubicin—ovarian cancer	4.54e-05	0.000303	CcSEcCtD
Telmisartan—Diarrhoea—Doxorubicin—ovarian cancer	4.52e-05	0.000301	CcSEcCtD
Telmisartan—Rash—Epirubicin—ovarian cancer	4.5e-05	0.0003	CcSEcCtD
Telmisartan—Dermatitis—Epirubicin—ovarian cancer	4.5e-05	0.0003	CcSEcCtD
Telmisartan—Headache—Epirubicin—ovarian cancer	4.47e-05	0.000298	CcSEcCtD
Telmisartan—Dizziness—Doxorubicin—ovarian cancer	4.37e-05	0.000291	CcSEcCtD
Telmisartan—Nausea—Epirubicin—ovarian cancer	4.24e-05	0.000283	CcSEcCtD
Telmisartan—Vomiting—Doxorubicin—ovarian cancer	4.2e-05	0.00028	CcSEcCtD
Telmisartan—Rash—Doxorubicin—ovarian cancer	4.17e-05	0.000278	CcSEcCtD
Telmisartan—Dermatitis—Doxorubicin—ovarian cancer	4.16e-05	0.000277	CcSEcCtD
Telmisartan—Headache—Doxorubicin—ovarian cancer	4.14e-05	0.000276	CcSEcCtD
Telmisartan—Nausea—Doxorubicin—ovarian cancer	3.93e-05	0.000262	CcSEcCtD
Telmisartan—AGTR1—Gastrin-CREB signalling pathway via PKC and MAPK—MAPK1—ovarian cancer	3.91e-05	0.0013	CbGpPWpGaD
Telmisartan—AGTR1—Gastrin-CREB signalling pathway via PKC and MAPK—EGFR—ovarian cancer	3.91e-05	0.0013	CbGpPWpGaD
Telmisartan—ABCG2—HIF-1-alpha transcription factor network—AKT1—ovarian cancer	3.87e-05	0.00129	CbGpPWpGaD
Telmisartan—SLCO1B3—Transmembrane transport of small molecules—ABCB1—ovarian cancer	3.84e-05	0.00128	CbGpPWpGaD
Telmisartan—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—MYC—ovarian cancer	3.83e-05	0.00128	CbGpPWpGaD
Telmisartan—AGTR1—G alpha (q) signalling events—PIK3CA—ovarian cancer	3.79e-05	0.00127	CbGpPWpGaD
Telmisartan—PPARG—Circadian rythm related genes—PTEN—ovarian cancer	3.78e-05	0.00126	CbGpPWpGaD
Telmisartan—PPARG—Metabolism—BRIP1—ovarian cancer	3.74e-05	0.00125	CbGpPWpGaD
Telmisartan—PPARG—Metabolism—PPP1CC—ovarian cancer	3.74e-05	0.00125	CbGpPWpGaD
Telmisartan—ABCB1—Integrated Pancreatic Cancer Pathway—BRCA1—ovarian cancer	3.71e-05	0.00124	CbGpPWpGaD
Telmisartan—AGTR1—Gastrin-CREB signalling pathway via PKC and MAPK—KRAS—ovarian cancer	3.69e-05	0.00123	CbGpPWpGaD
Telmisartan—ABCC2—Transmembrane transport of small molecules—SLC5A5—ovarian cancer	3.6e-05	0.0012	CbGpPWpGaD
Telmisartan—ABCB1—Allograft Rejection—CXCL8—ovarian cancer	3.5e-05	0.00117	CbGpPWpGaD
Telmisartan—ABCC2—Transmembrane transport of small molecules—SLC2A1—ovarian cancer	3.48e-05	0.00116	CbGpPWpGaD
Telmisartan—AGTR1—Gastrin-CREB signalling pathway via PKC and MAPK—PIK3CA—ovarian cancer	3.39e-05	0.00113	CbGpPWpGaD
Telmisartan—CYP2C19—Metabolism of lipids and lipoproteins—PPP1CC—ovarian cancer	3.39e-05	0.00113	CbGpPWpGaD
Telmisartan—ABCB1—Integrated Pancreatic Cancer Pathway—BRCA2—ovarian cancer	3.36e-05	0.00112	CbGpPWpGaD
Telmisartan—ABCB1—Transmembrane transport of small molecules—AQP3—ovarian cancer	3.35e-05	0.00112	CbGpPWpGaD
Telmisartan—ABCB1—Allograft Rejection—CASP3—ovarian cancer	3.35e-05	0.00112	CbGpPWpGaD
Telmisartan—PPARG—Adipogenesis—IL6—ovarian cancer	3.34e-05	0.00112	CbGpPWpGaD
Telmisartan—ABCB1—Allograft Rejection—IL2—ovarian cancer	3.34e-05	0.00111	CbGpPWpGaD
Telmisartan—ABCB1—HIF-1-alpha transcription factor network—VEGFA—ovarian cancer	3.28e-05	0.00109	CbGpPWpGaD
Telmisartan—ABCB1—Integrated Pancreatic Cancer Pathway—CCNE1—ovarian cancer	3.25e-05	0.00108	CbGpPWpGaD
Telmisartan—PPARG—Gene Expression—YAP1—ovarian cancer	3.23e-05	0.00108	CbGpPWpGaD
Telmisartan—ABCB1—Transmembrane transport of small molecules—ATP7B—ovarian cancer	3.21e-05	0.00107	CbGpPWpGaD
Telmisartan—SLCO1B3—Metabolism of lipids and lipoproteins—CAV1—ovarian cancer	3.19e-05	0.00107	CbGpPWpGaD
Telmisartan—ABCB1—Integrated Pancreatic Cancer Pathway—TYMS—ovarian cancer	3.19e-05	0.00107	CbGpPWpGaD
Telmisartan—AGTR1—Signaling Pathways—HDAC6—ovarian cancer	3.18e-05	0.00106	CbGpPWpGaD
Telmisartan—AGTR1—Signaling by GPCR—PPP2R1A—ovarian cancer	3.14e-05	0.00105	CbGpPWpGaD
Telmisartan—AGTR1—Gastrin-CREB signalling pathway via PKC and MAPK—HRAS—ovarian cancer	3.14e-05	0.00105	CbGpPWpGaD
Telmisartan—ABCG2—Transmembrane transport of small molecules—SLC5A5—ovarian cancer	3.13e-05	0.00104	CbGpPWpGaD
Telmisartan—PPARG—Generic Transcription Pathway—ESR1—ovarian cancer	3.12e-05	0.00104	CbGpPWpGaD
Telmisartan—ABCG2—Metabolism—CYTB—ovarian cancer	3.12e-05	0.00104	CbGpPWpGaD
Telmisartan—ABCG2—Transmembrane transport of small molecules—SLC2A1—ovarian cancer	3.02e-05	0.00101	CbGpPWpGaD
Telmisartan—AGTR1—GPCR ligand binding—CXCL8—ovarian cancer	3.02e-05	0.00101	CbGpPWpGaD
Telmisartan—AGTR1—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—ovarian cancer	3e-05	0.001	CbGpPWpGaD
Telmisartan—PPARG—Developmental Biology—MET—ovarian cancer	2.95e-05	0.000985	CbGpPWpGaD
Telmisartan—SLCO1B3—Metabolism—YAP1—ovarian cancer	2.94e-05	0.000981	CbGpPWpGaD
Telmisartan—Candesartan—ABCB1—ovarian cancer	2.91e-05	0.608	CrCbGaD
Telmisartan—SLCO1B3—Metabolism of lipids and lipoproteins—PIK3CG—ovarian cancer	2.91e-05	0.000971	CbGpPWpGaD
Telmisartan—PPARG—Developmental Biology—IL6ST—ovarian cancer	2.89e-05	0.000965	CbGpPWpGaD
Telmisartan—ABCB1—Allograft Rejection—VEGFA—ovarian cancer	2.84e-05	0.000948	CbGpPWpGaD
Telmisartan—AGTR1—Signaling Pathways—YAP1—ovarian cancer	2.82e-05	0.00094	CbGpPWpGaD
Telmisartan—PPARG—Gene Expression—PGR—ovarian cancer	2.82e-05	0.00094	CbGpPWpGaD
Telmisartan—AGTR1—Signaling Pathways—XIAP—ovarian cancer	2.76e-05	0.000921	CbGpPWpGaD
Telmisartan—ABCC2—Transmembrane transport of small molecules—ABCB1—ovarian cancer	2.74e-05	0.000916	CbGpPWpGaD
Telmisartan—ABCG2—Metabolism—PPP1CC—ovarian cancer	2.73e-05	0.00091	CbGpPWpGaD
Telmisartan—ABCG2—Metabolism—BRIP1—ovarian cancer	2.73e-05	0.00091	CbGpPWpGaD
Telmisartan—PPARG—Metabolism of lipids and lipoproteins—CAV1—ovarian cancer	2.72e-05	0.000909	CbGpPWpGaD
Telmisartan—AGTR1—Signaling Pathways—SMARCA4—ovarian cancer	2.69e-05	0.000897	CbGpPWpGaD
Telmisartan—CYP2C19—Metabolism—NME2—ovarian cancer	2.68e-05	0.000895	CbGpPWpGaD
Telmisartan—AGTR1—Signaling Pathways—EREG—ovarian cancer	2.62e-05	0.000876	CbGpPWpGaD
Telmisartan—PPARG—Gene Expression—PARP1—ovarian cancer	2.62e-05	0.000874	CbGpPWpGaD
Telmisartan—ABCB1—Metabolism—NME2—ovarian cancer	2.62e-05	0.000873	CbGpPWpGaD
Telmisartan—PPARG—Circadian rythm related genes—TP53—ovarian cancer	2.58e-05	0.00086	CbGpPWpGaD
Telmisartan—SLCO1B3—Metabolism of lipids and lipoproteins—PIK3CD—ovarian cancer	2.56e-05	0.000853	CbGpPWpGaD
Telmisartan—ABCB1—Transmembrane transport of small molecules—TUBB3—ovarian cancer	2.54e-05	0.000847	CbGpPWpGaD
Telmisartan—PPARG—Metabolism—YAP1—ovarian cancer	2.51e-05	0.000837	CbGpPWpGaD
Telmisartan—PPARG—Metabolism of lipids and lipoproteins—PIK3CG—ovarian cancer	2.48e-05	0.000828	CbGpPWpGaD
Telmisartan—ABCB1—Integrated Pancreatic Cancer Pathway—ESR1—ovarian cancer	2.48e-05	0.000827	CbGpPWpGaD
Telmisartan—PPARG—Developmental Biology—MMP2—ovarian cancer	2.46e-05	0.000822	CbGpPWpGaD
Telmisartan—AGTR1—Signaling Pathways—PGR—ovarian cancer	2.46e-05	0.000821	CbGpPWpGaD
Telmisartan—SLCO1B3—Metabolism—FASN—ovarian cancer	2.4e-05	0.0008	CbGpPWpGaD
Telmisartan—ABCG2—Transmembrane transport of small molecules—ABCB1—ovarian cancer	2.39e-05	0.000797	CbGpPWpGaD
Telmisartan—PPARG—Circadian rythm related genes—IL6—ovarian cancer	2.36e-05	0.000788	CbGpPWpGaD
Telmisartan—SLCO1B3—Metabolism—SLC5A5—ovarian cancer	2.36e-05	0.000787	CbGpPWpGaD
Telmisartan—ABCB1—Integrated Pancreatic Cancer Pathway—APC—ovarian cancer	2.34e-05	0.000782	CbGpPWpGaD
Telmisartan—AGTR1—GPCR downstream signaling—PIK3CG—ovarian cancer	2.31e-05	0.000772	CbGpPWpGaD
Telmisartan—AGTR1—Signaling Pathways—PARP1—ovarian cancer	2.29e-05	0.000763	CbGpPWpGaD
Telmisartan—SLCO1B3—Metabolism—SLC2A1—ovarian cancer	2.28e-05	0.00076	CbGpPWpGaD
Telmisartan—CYP2C19—Metabolism of lipids and lipoproteins—YAP1—ovarian cancer	2.27e-05	0.000759	CbGpPWpGaD
Telmisartan—SLCO1B3—Metabolism of lipids and lipoproteins—PIK3CB—ovarian cancer	2.23e-05	0.000744	CbGpPWpGaD
Telmisartan—AGTR1—Signaling by GPCR—IL6ST—ovarian cancer	2.19e-05	0.00073	CbGpPWpGaD
Telmisartan—SLCO1B3—Metabolism—CYP1B1—ovarian cancer	2.18e-05	0.000728	CbGpPWpGaD
Telmisartan—PPARG—Metabolism of lipids and lipoproteins—PIK3CD—ovarian cancer	2.18e-05	0.000728	CbGpPWpGaD
Telmisartan—PPARG—Developmental Biology—ERBB2—ovarian cancer	2.16e-05	0.00072	CbGpPWpGaD
Telmisartan—PPARG—Gene Expression—PPP2R1A—ovarian cancer	2.12e-05	0.000709	CbGpPWpGaD
Telmisartan—AGTR1—Signaling by GPCR—PIK3CG—ovarian cancer	2.1e-05	0.000701	CbGpPWpGaD
Telmisartan—ABCB1—HIF-1-alpha transcription factor network—AKT1—ovarian cancer	2.09e-05	0.000698	CbGpPWpGaD
Telmisartan—PPARG—Metabolism—FASN—ovarian cancer	2.04e-05	0.000682	CbGpPWpGaD
Telmisartan—AGTR1—GPCR downstream signaling—PIK3CD—ovarian cancer	2.03e-05	0.000679	CbGpPWpGaD
Telmisartan—PPARG—Metabolism—SLC5A5—ovarian cancer	2.01e-05	0.000671	CbGpPWpGaD
Telmisartan—PPARG—Metabolism—SLC2A1—ovarian cancer	1.94e-05	0.000648	CbGpPWpGaD
Telmisartan—SLCO1B3—Metabolism—PPP2R1A—ovarian cancer	1.94e-05	0.000646	CbGpPWpGaD
Telmisartan—SLCO1B3—Metabolism of lipids and lipoproteins—PTEN—ovarian cancer	1.93e-05	0.000643	CbGpPWpGaD
Telmisartan—PPARG—Metabolism of lipids and lipoproteins—PIK3CB—ovarian cancer	1.9e-05	0.000635	CbGpPWpGaD
Telmisartan—PPARG—Developmental Biology—CTNNB1—ovarian cancer	1.89e-05	0.00063	CbGpPWpGaD
Telmisartan—Losartan—ABCB1—ovarian cancer	1.88e-05	0.392	CrCbGaD
Telmisartan—PPARG—Metabolism—CYP1B1—ovarian cancer	1.86e-05	0.000621	CbGpPWpGaD
Telmisartan—AGTR1—Signaling Pathways—PPP2R1A—ovarian cancer	1.85e-05	0.000619	CbGpPWpGaD
Telmisartan—CYP2C19—Metabolism of lipids and lipoproteins—FASN—ovarian cancer	1.85e-05	0.000619	CbGpPWpGaD
Telmisartan—PPARG—Developmental Biology—MMP9—ovarian cancer	1.85e-05	0.000618	CbGpPWpGaD
Telmisartan—AGTR1—Signaling by GPCR—PIK3CD—ovarian cancer	1.85e-05	0.000616	CbGpPWpGaD
Telmisartan—ABCG2—Metabolism—YAP1—ovarian cancer	1.83e-05	0.00061	CbGpPWpGaD
Telmisartan—ABCB1—Integrated Pancreatic Cancer Pathway—ERBB2—ovarian cancer	1.82e-05	0.000607	CbGpPWpGaD
Telmisartan—SLCO1B3—Metabolism—ABCB1—ovarian cancer	1.8e-05	0.0006	CbGpPWpGaD
Telmisartan—AGTR1—GPCR downstream signaling—PIK3CB—ovarian cancer	1.77e-05	0.000592	CbGpPWpGaD
Telmisartan—SLCO1B3—Metabolism—TYMS—ovarian cancer	1.76e-05	0.000589	CbGpPWpGaD
Telmisartan—CYP2C19—Metabolism—CYTB—ovarian cancer	1.73e-05	0.000577	CbGpPWpGaD
Telmisartan—AGTR1—GPCR downstream signaling—CXCL8—ovarian cancer	1.7e-05	0.000569	CbGpPWpGaD
Telmisartan—ABCB1—Transmembrane transport of small molecules—SLC5A5—ovarian cancer	1.69e-05	0.000565	CbGpPWpGaD
Telmisartan—CYP2C19—Metabolism of lipids and lipoproteins—CYP1B1—ovarian cancer	1.69e-05	0.000564	CbGpPWpGaD
Telmisartan—ABCB1—Metabolism—CYTB—ovarian cancer	1.69e-05	0.000563	CbGpPWpGaD
Telmisartan—ABCB1—Integrated Pancreatic Cancer Pathway—CDKN1B—ovarian cancer	1.68e-05	0.000562	CbGpPWpGaD
Telmisartan—PPARG—Developmental Biology—VEGFA—ovarian cancer	1.66e-05	0.000555	CbGpPWpGaD
Telmisartan—PPARG—Metabolism—PPP2R1A—ovarian cancer	1.65e-05	0.000551	CbGpPWpGaD
Telmisartan—ABCB1—Integrated Pancreatic Cancer Pathway—CASP3—ovarian cancer	1.65e-05	0.000551	CbGpPWpGaD
Telmisartan—PPARG—Developmental Biology—STAT3—ovarian cancer	1.65e-05	0.000549	CbGpPWpGaD
Telmisartan—PPARG—Metabolism of lipids and lipoproteins—PTEN—ovarian cancer	1.64e-05	0.000548	CbGpPWpGaD
Telmisartan—PPARG—Developmental Biology—NRAS—ovarian cancer	1.64e-05	0.000548	CbGpPWpGaD
Telmisartan—ABCB1—Transmembrane transport of small molecules—SLC2A1—ovarian cancer	1.63e-05	0.000545	CbGpPWpGaD
Telmisartan—AGTR1—GPCR downstream signaling—IL2—ovarian cancer	1.63e-05	0.000543	CbGpPWpGaD
Telmisartan—PPARG—Generic Transcription Pathway—MYC—ovarian cancer	1.62e-05	0.000542	CbGpPWpGaD
Telmisartan—AGTR1—Signaling by GPCR—PIK3CB—ovarian cancer	1.61e-05	0.000537	CbGpPWpGaD
Telmisartan—ABCB1—Integrated Pancreatic Cancer Pathway—CCND1—ovarian cancer	1.61e-05	0.000536	CbGpPWpGaD
Telmisartan—ABCB1—Integrated Pancreatic Cancer Pathway—CTNNB1—ovarian cancer	1.59e-05	0.000531	CbGpPWpGaD
Telmisartan—PPARG—Developmental Biology—MAPK3—ovarian cancer	1.57e-05	0.000525	CbGpPWpGaD
Telmisartan—ABCB1—Integrated Pancreatic Cancer Pathway—PTEN—ovarian cancer	1.55e-05	0.000518	CbGpPWpGaD
Telmisartan—AGTR1—Signaling by GPCR—CXCL8—ovarian cancer	1.55e-05	0.000516	CbGpPWpGaD
Telmisartan—PPARG—Metabolism—ABCB1—ovarian cancer	1.53e-05	0.000512	CbGpPWpGaD
Telmisartan—CYP2C19—Metabolism—PPP1CC—ovarian cancer	1.51e-05	0.000504	CbGpPWpGaD
Telmisartan—CYP2C19—Metabolism—BRIP1—ovarian cancer	1.51e-05	0.000504	CbGpPWpGaD
Telmisartan—PPARG—Metabolism—TYMS—ovarian cancer	1.51e-05	0.000503	CbGpPWpGaD
Telmisartan—PPARG—Gene Expression—ESR1—ovarian cancer	1.5e-05	0.000502	CbGpPWpGaD
Telmisartan—PPARG—Developmental Biology—MAPK1—ovarian cancer	1.5e-05	0.000499	CbGpPWpGaD
Telmisartan—PPARG—Developmental Biology—EGFR—ovarian cancer	1.5e-05	0.000499	CbGpPWpGaD
Telmisartan—ABCG2—Metabolism—FASN—ovarian cancer	1.49e-05	0.000497	CbGpPWpGaD
Telmisartan—AGTR1—Signaling by GPCR—IL2—ovarian cancer	1.48e-05	0.000493	CbGpPWpGaD
Telmisartan—ABCB1—Metabolism—BRIP1—ovarian cancer	1.47e-05	0.000492	CbGpPWpGaD
Telmisartan—ABCB1—Metabolism—PPP1CC—ovarian cancer	1.47e-05	0.000492	CbGpPWpGaD
Telmisartan—AGTR1—Signaling Pathways—TERT—ovarian cancer	1.47e-05	0.000492	CbGpPWpGaD
Telmisartan—ABCG2—Metabolism—SLC5A5—ovarian cancer	1.47e-05	0.000489	CbGpPWpGaD
Telmisartan—SLCO1B3—Metabolism—CAV1—ovarian cancer	1.42e-05	0.000475	CbGpPWpGaD
Telmisartan—ABCG2—Metabolism—SLC2A1—ovarian cancer	1.42e-05	0.000473	CbGpPWpGaD
Telmisartan—PPARG—Developmental Biology—KRAS—ovarian cancer	1.41e-05	0.000472	CbGpPWpGaD
Telmisartan—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—ovarian cancer	1.4e-05	0.000468	CbGpPWpGaD
Telmisartan—AGTR1—Signaling Pathways—CAV1—ovarian cancer	1.36e-05	0.000455	CbGpPWpGaD
Telmisartan—SLCO1B3—Metabolism of lipids and lipoproteins—PIK3CA—ovarian cancer	1.36e-05	0.000453	CbGpPWpGaD
Telmisartan—ABCG2—Metabolism—CYP1B1—ovarian cancer	1.36e-05	0.000453	CbGpPWpGaD
Telmisartan—ABCB1—Integrated Pancreatic Cancer Pathway—MAPK3—ovarian cancer	1.33e-05	0.000442	CbGpPWpGaD
Telmisartan—AGTR1—Signaling Pathways—ESR1—ovarian cancer	1.31e-05	0.000438	CbGpPWpGaD
Telmisartan—SLCO1B3—Metabolism—PIK3CG—ovarian cancer	1.3e-05	0.000432	CbGpPWpGaD
Telmisartan—AGTR1—Signaling Pathways—IL6ST—ovarian cancer	1.29e-05	0.000431	CbGpPWpGaD
Telmisartan—ABCB1—Integrated Pancreatic Cancer Pathway—MYC—ovarian cancer	1.29e-05	0.00043	CbGpPWpGaD
Telmisartan—ABCB1—Integrated Pancreatic Cancer Pathway—MAPK1—ovarian cancer	1.26e-05	0.000421	CbGpPWpGaD
Telmisartan—ABCB1—Integrated Pancreatic Cancer Pathway—EGFR—ovarian cancer	1.26e-05	0.000421	CbGpPWpGaD
Telmisartan—AGTR1—Signaling Pathways—APC—ovarian cancer	1.24e-05	0.000414	CbGpPWpGaD
Telmisartan—AGTR1—Signaling Pathways—PIK3CG—ovarian cancer	1.24e-05	0.000414	CbGpPWpGaD
Telmisartan—AGTR1—Signaling by GPCR—NRAS—ovarian cancer	1.24e-05	0.000414	CbGpPWpGaD
Telmisartan—PPARG—Metabolism—CAV1—ovarian cancer	1.21e-05	0.000405	CbGpPWpGaD
Telmisartan—ABCG2—Metabolism—PPP2R1A—ovarian cancer	1.2e-05	0.000402	CbGpPWpGaD
Telmisartan—PPARG—Developmental Biology—HRAS—ovarian cancer	1.2e-05	0.000401	CbGpPWpGaD
Telmisartan—ABCB1—Integrated Pancreatic Cancer Pathway—KRAS—ovarian cancer	1.19e-05	0.000398	CbGpPWpGaD
Telmisartan—AGTR1—Signaling by GPCR—MAPK3—ovarian cancer	1.19e-05	0.000397	CbGpPWpGaD
Telmisartan—PPARG—Metabolism of lipids and lipoproteins—PIK3CA—ovarian cancer	1.16e-05	0.000387	CbGpPWpGaD
Telmisartan—PPARG—Developmental Biology—IL6—ovarian cancer	1.15e-05	0.000384	CbGpPWpGaD
Telmisartan—SLCO1B3—Metabolism—PIK3CD—ovarian cancer	1.14e-05	0.00038	CbGpPWpGaD
Telmisartan—AGTR1—Signaling by GPCR—MAPK1—ovarian cancer	1.13e-05	0.000377	CbGpPWpGaD
Telmisartan—AGTR1—Signaling by GPCR—EGFR—ovarian cancer	1.13e-05	0.000377	CbGpPWpGaD
Telmisartan—ABCG2—Metabolism—ABCB1—ovarian cancer	1.12e-05	0.000373	CbGpPWpGaD
Telmisartan—PPARG—Metabolism—PIK3CG—ovarian cancer	1.11e-05	0.000369	CbGpPWpGaD
Telmisartan—CYP2C19—Metabolism of lipids and lipoproteins—CAV1—ovarian cancer	1.1e-05	0.000367	CbGpPWpGaD
Telmisartan—ABCG2—Metabolism—TYMS—ovarian cancer	1.1e-05	0.000366	CbGpPWpGaD
Telmisartan—ABCB1—Integrated Pancreatic Cancer Pathway—PIK3CA—ovarian cancer	1.09e-05	0.000365	CbGpPWpGaD
Telmisartan—AGTR1—Signaling Pathways—PIK3CD—ovarian cancer	1.09e-05	0.000364	CbGpPWpGaD
Telmisartan—AGTR1—GPCR downstream signaling—PIK3CA—ovarian cancer	1.08e-05	0.000361	CbGpPWpGaD
Telmisartan—AGTR1—Signaling by GPCR—KRAS—ovarian cancer	1.07e-05	0.000357	CbGpPWpGaD
Telmisartan—PPARG—Developmental Biology—AKT1—ovarian cancer	1.06e-05	0.000354	CbGpPWpGaD
Telmisartan—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—ovarian cancer	1.06e-05	0.000353	CbGpPWpGaD
Telmisartan—CYP2C19—Metabolism—YAP1—ovarian cancer	1.01e-05	0.000338	CbGpPWpGaD
Telmisartan—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CG—ovarian cancer	1e-05	0.000335	CbGpPWpGaD
Telmisartan—SLCO1B3—Metabolism—PIK3CB—ovarian cancer	9.93e-06	0.000331	CbGpPWpGaD
Telmisartan—ABCB1—Metabolism—YAP1—ovarian cancer	9.89e-06	0.00033	CbGpPWpGaD
Telmisartan—AGTR1—Signaling by GPCR—PIK3CA—ovarian cancer	9.82e-06	0.000328	CbGpPWpGaD
Telmisartan—PPARG—Metabolism—PIK3CD—ovarian cancer	9.72e-06	0.000324	CbGpPWpGaD
Telmisartan—AGTR1—Signaling Pathways—ERBB2—ovarian cancer	9.64e-06	0.000322	CbGpPWpGaD
Telmisartan—AGTR1—Signaling Pathways—MTOR—ovarian cancer	9.51e-06	0.000317	CbGpPWpGaD
Telmisartan—AGTR1—Signaling Pathways—PIK3CB—ovarian cancer	9.51e-06	0.000317	CbGpPWpGaD
Telmisartan—AGTR1—Signaling Pathways—CXCL8—ovarian cancer	9.14e-06	0.000305	CbGpPWpGaD
Telmisartan—AGTR1—Signaling by GPCR—HRAS—ovarian cancer	9.08e-06	0.000303	CbGpPWpGaD
Telmisartan—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—ovarian cancer	8.94e-06	0.000298	CbGpPWpGaD
Telmisartan—AGTR1—Signaling Pathways—CDKN1B—ovarian cancer	8.93e-06	0.000298	CbGpPWpGaD
Telmisartan—ABCG2—Metabolism—CAV1—ovarian cancer	8.85e-06	0.000295	CbGpPWpGaD
Telmisartan—AGTR1—GPCR downstream signaling—AKT1—ovarian cancer	8.83e-06	0.000295	CbGpPWpGaD
Telmisartan—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CD—ovarian cancer	8.81e-06	0.000294	CbGpPWpGaD
Telmisartan—AGTR1—Signaling Pathways—CASP3—ovarian cancer	8.75e-06	0.000292	CbGpPWpGaD
Telmisartan—AGTR1—Signaling Pathways—IL2—ovarian cancer	8.74e-06	0.000292	CbGpPWpGaD
Telmisartan—AGTR1—Signaling by GPCR—IL6—ovarian cancer	8.69e-06	0.00029	CbGpPWpGaD
Telmisartan—SLCO1B3—Metabolism—PTEN—ovarian cancer	8.58e-06	0.000286	CbGpPWpGaD
Telmisartan—AGTR1—Signaling Pathways—CCND1—ovarian cancer	8.52e-06	0.000284	CbGpPWpGaD
Telmisartan—PPARG—Metabolism—PIK3CB—ovarian cancer	8.47e-06	0.000283	CbGpPWpGaD
Telmisartan—AGTR1—Signaling Pathways—CTNNB1—ovarian cancer	8.43e-06	0.000281	CbGpPWpGaD
Telmisartan—AGTR1—Signaling Pathways—MMP9—ovarian cancer	8.27e-06	0.000276	CbGpPWpGaD
Telmisartan—CYP2C19—Metabolism—FASN—ovarian cancer	8.26e-06	0.000276	CbGpPWpGaD
Telmisartan—AGTR1—Signaling Pathways—PTEN—ovarian cancer	8.22e-06	0.000274	CbGpPWpGaD
Telmisartan—CYP2C19—Metabolism—SLC5A5—ovarian cancer	8.12e-06	0.000271	CbGpPWpGaD
Telmisartan—ABCB1—Metabolism—FASN—ovarian cancer	8.06e-06	0.000269	CbGpPWpGaD
Telmisartan—ABCG2—Metabolism—PIK3CG—ovarian cancer	8.06e-06	0.000269	CbGpPWpGaD
Telmisartan—PPARG—Gene Expression—MAPK3—ovarian cancer	8.04e-06	0.000268	CbGpPWpGaD
Telmisartan—AGTR1—Signaling by GPCR—AKT1—ovarian cancer	8.02e-06	0.000268	CbGpPWpGaD
Telmisartan—ABCB1—Metabolism—SLC5A5—ovarian cancer	7.93e-06	0.000265	CbGpPWpGaD
Telmisartan—CYP2C19—Metabolism—SLC2A1—ovarian cancer	7.84e-06	0.000262	CbGpPWpGaD
Telmisartan—PPARG—Gene Expression—MYC—ovarian cancer	7.82e-06	0.000261	CbGpPWpGaD
Telmisartan—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CB—ovarian cancer	7.68e-06	0.000256	CbGpPWpGaD
Telmisartan—ABCB1—Metabolism—SLC2A1—ovarian cancer	7.66e-06	0.000255	CbGpPWpGaD
Telmisartan—CYP2C19—Metabolism—CYP1B1—ovarian cancer	7.52e-06	0.000251	CbGpPWpGaD
Telmisartan—AGTR1—Signaling Pathways—VEGFA—ovarian cancer	7.42e-06	0.000248	CbGpPWpGaD
Telmisartan—AGTR1—Signaling Pathways—STAT3—ovarian cancer	7.35e-06	0.000245	CbGpPWpGaD
Telmisartan—ABCB1—Metabolism—CYP1B1—ovarian cancer	7.34e-06	0.000245	CbGpPWpGaD
Telmisartan—AGTR1—Signaling Pathways—NRAS—ovarian cancer	7.33e-06	0.000245	CbGpPWpGaD
Telmisartan—PPARG—Metabolism—PTEN—ovarian cancer	7.32e-06	0.000244	CbGpPWpGaD
Telmisartan—ABCG2—Metabolism—PIK3CD—ovarian cancer	7.08e-06	0.000236	CbGpPWpGaD
Telmisartan—AGTR1—Signaling Pathways—MAPK3—ovarian cancer	7.02e-06	0.000234	CbGpPWpGaD
Telmisartan—AGTR1—Signaling Pathways—MYC—ovarian cancer	6.83e-06	0.000228	CbGpPWpGaD
Telmisartan—AGTR1—Signaling Pathways—MAPK1—ovarian cancer	6.68e-06	0.000223	CbGpPWpGaD
Telmisartan—AGTR1—Signaling Pathways—EGFR—ovarian cancer	6.68e-06	0.000223	CbGpPWpGaD
Telmisartan—CYP2C19—Metabolism—PPP2R1A—ovarian cancer	6.67e-06	0.000223	CbGpPWpGaD
Telmisartan—CYP2C19—Metabolism of lipids and lipoproteins—PTEN—ovarian cancer	6.64e-06	0.000221	CbGpPWpGaD
Telmisartan—ABCB1—Metabolism—PPP2R1A—ovarian cancer	6.51e-06	0.000217	CbGpPWpGaD
Telmisartan—AGTR1—Signaling Pathways—KRAS—ovarian cancer	6.31e-06	0.000211	CbGpPWpGaD
Telmisartan—CYP2C19—Metabolism—ABCB1—ovarian cancer	6.19e-06	0.000207	CbGpPWpGaD
Telmisartan—ABCG2—Metabolism—PIK3CB—ovarian cancer	6.17e-06	0.000206	CbGpPWpGaD
Telmisartan—CYP2C19—Metabolism—TYMS—ovarian cancer	6.08e-06	0.000203	CbGpPWpGaD
Telmisartan—SLCO1B3—Metabolism—PIK3CA—ovarian cancer	6.05e-06	0.000202	CbGpPWpGaD
Telmisartan—ABCB1—Metabolism—TYMS—ovarian cancer	5.94e-06	0.000198	CbGpPWpGaD
Telmisartan—AGTR1—Signaling Pathways—PIK3CA—ovarian cancer	5.8e-06	0.000194	CbGpPWpGaD
Telmisartan—AGTR1—Signaling Pathways—TP53—ovarian cancer	5.61e-06	0.000187	CbGpPWpGaD
Telmisartan—PPARG—Gene Expression—AKT1—ovarian cancer	5.42e-06	0.000181	CbGpPWpGaD
Telmisartan—AGTR1—Signaling Pathways—HRAS—ovarian cancer	5.36e-06	0.000179	CbGpPWpGaD
Telmisartan—ABCG2—Metabolism—PTEN—ovarian cancer	5.34e-06	0.000178	CbGpPWpGaD
Telmisartan—PPARG—Metabolism—PIK3CA—ovarian cancer	5.16e-06	0.000172	CbGpPWpGaD
Telmisartan—AGTR1—Signaling Pathways—IL6—ovarian cancer	5.13e-06	0.000171	CbGpPWpGaD
Telmisartan—SLCO1B3—Metabolism—AKT1—ovarian cancer	4.94e-06	0.000165	CbGpPWpGaD
Telmisartan—CYP2C19—Metabolism—CAV1—ovarian cancer	4.9e-06	0.000164	CbGpPWpGaD
Telmisartan—ABCB1—Metabolism—CAV1—ovarian cancer	4.78e-06	0.00016	CbGpPWpGaD
Telmisartan—AGTR1—Signaling Pathways—AKT1—ovarian cancer	4.74e-06	0.000158	CbGpPWpGaD
Telmisartan—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CA—ovarian cancer	4.68e-06	0.000156	CbGpPWpGaD
Telmisartan—CYP2C19—Metabolism—PIK3CG—ovarian cancer	4.46e-06	0.000149	CbGpPWpGaD
Telmisartan—ABCB1—Metabolism—PIK3CG—ovarian cancer	4.36e-06	0.000145	CbGpPWpGaD
Telmisartan—PPARG—Metabolism—AKT1—ovarian cancer	4.22e-06	0.000141	CbGpPWpGaD
Telmisartan—CYP2C19—Metabolism—PIK3CD—ovarian cancer	3.92e-06	0.000131	CbGpPWpGaD
Telmisartan—ABCB1—Metabolism—PIK3CD—ovarian cancer	3.83e-06	0.000128	CbGpPWpGaD
Telmisartan—ABCG2—Metabolism—PIK3CA—ovarian cancer	3.76e-06	0.000126	CbGpPWpGaD
Telmisartan—CYP2C19—Metabolism—PIK3CB—ovarian cancer	3.42e-06	0.000114	CbGpPWpGaD
Telmisartan—ABCB1—Metabolism—PIK3CB—ovarian cancer	3.34e-06	0.000111	CbGpPWpGaD
Telmisartan—ABCG2—Metabolism—AKT1—ovarian cancer	3.08e-06	0.000103	CbGpPWpGaD
Telmisartan—CYP2C19—Metabolism—PTEN—ovarian cancer	2.96e-06	9.86e-05	CbGpPWpGaD
Telmisartan—ABCB1—Metabolism—PTEN—ovarian cancer	2.88e-06	9.63e-05	CbGpPWpGaD
Telmisartan—CYP2C19—Metabolism—PIK3CA—ovarian cancer	2.09e-06	6.96e-05	CbGpPWpGaD
Telmisartan—ABCB1—Metabolism—PIK3CA—ovarian cancer	2.04e-06	6.79e-05	CbGpPWpGaD
Telmisartan—CYP2C19—Metabolism—AKT1—ovarian cancer	1.7e-06	5.68e-05	CbGpPWpGaD
Telmisartan—ABCB1—Metabolism—AKT1—ovarian cancer	1.66e-06	5.55e-05	CbGpPWpGaD
